Virbac SA (VRBCF)
OTCMKTS · Delayed Price · Currency is USD
436.32
+90.32 (26.10%)
At close: Dec 2, 2025
Virbac Market Cap
Virbac has a market cap or net worth of $3.54 billion as of February 12, 2026. Its market cap has increased by 25.48% in one year.
Market Cap
3.54B
Enterprise Value
3.76B
Revenue
1.68B
Ranking
n/a
PE Ratio
22.65
Stock Price
$436.32
Market Cap Chart
Since August 8, 1994, Virbac's market cap has increased from 263.48M to 3.54B, an increase of 1,243.08%. That is a compound annual growth rate of 8.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 3.56B | 1.36% |
| Dec 31, 2025 | 3.52B | 28.15% |
| Dec 31, 2024 | 2.74B | -18.21% |
| Dec 29, 2023 | 3.36B | 62.92% |
| Dec 30, 2022 | 2.06B | -49.48% |
| Dec 31, 2021 | 4.08B | 65.97% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 805.86M |
| Glass House Brands | 756.71M |
| Elite Pharmaceuticals | 481.05M |
| Northwest Biotherapeutics | 406.62M |
| Nika Pharmaceuticals | 403.38M |
| American Oncology Network | 377.98M |
| CytoDyn | 317.38M |
| OpGen | 310.55M |